Skip to main content
Veterinary Medicines

Primun Gumboro W2512

Authorised
  • Infectious bursal disease virus, strain Winterfield 2512, Live

Product identification

Medicine name:
Primun Gumboro W2512
Primun Gumboro W2512 liofilizat pentru utilizare în apa de băut pentru găini
Active substance:
  • Infectious bursal disease virus, strain Winterfield 2512, Live
Target species:
  • Chicken (broiler)
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain Winterfield 2512, Live
    3.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (broiler)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:
  • cardboard box containing 1 vial of 1.000 doses
  • box of plastic containing 10 vials of 1.000 doses
  • Cardboard box containing 1 vial of 5000 doses
  • Cardboard box containing 10 vials of 5000 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 240041
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0273/001
Concerned member states:
  • Belgium
  • France
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Romania

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 2/04/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."